IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q3 2025 Holdings

Filed 2025-10-17 | 5 holdings | $744.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$484.1M19,963,15765.0%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$87.9M7,464,57211.8%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$81.6M2,869,56511.0%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$72.1M2,794,0009.7%
Aura Biosciences Inc(AURA)COM05153U107$18.8M3,039,8922.5%